Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 12 ... bioterrorism pathogens such as B. anthracis, Yersinia pestis (plaque), Brucella and smallpox that are of concern to the safety of the human plasma supply chain. In addition to ...
2009 NOV 23 ... transplant patients and as a biodefense countermeasure in the event of a smallpox release. Mr. Moch will speak at the Lazard Capital Markets 6th Annual ...
2009 NOV 16 ... (GHSI). CMX001 is a broad-spectrum antiviral agent being developed for the treatment of smallpox, as well as other serious viral infections. Randall Lanier, Ph.D., Director ...
2009 OCT 12 ... to recent research from the United States, "The search for a 'third'-generation smallpox vaccine has resulted in the development and characterization of several vaccine ...
2009 OCT 19 ... against avian- (H5N1) and swine-origin (H1N1) influenza and a combination plague and smallpox vaccine for biodefense. Inviragen had offices in Fort Collins, Colorado and Madison, ...
2009 NOV 1 ... against seasonal and pandemic influenza, hepatitis B, RSV, HIV, pneumococcal, anthrax, smallpox and other diseases. The company's NanoStat™ adjuvant platform technology has ...
2009 NOV 16 ... viruses, hemorrhagic fever viruses, cytomegalovirus (CMV), measles and members of the smallpox and rabies virus families. Targeting PS thus provides a broad platform for treating ...
2009 OCT 19 ... influenza, herpes simplex viruses, hemorrhagic fever viruses, measles and members of the smallpox and rabies virus families. Scientists have also found that PS is exposed in certain ...
2009 OCT 5 ... methods should prove useful tools in monitoring immune responses to next-generation smallpox vaccines, studying poxvirus immunity, and evaluating therapeutic agents such as vaccinia ...
2009 NOV 2 ... DNA, DNA Virus, Protein Interaction, Proteins, Proteome Research, Proteomics, Smallpox, Vaccinia Virus, Variola Virus, Viral Research, Virology, University of Florida, Medical ...
2009 OCT 20 ... 20036-2904, USA. Keywords: United States, Gainesville, Cowpox, Cytokines, Smallpox, Vaccinia Virus, Variola Virus, Viral Research, Virology, University of Florida, Medical ...
2009 NOV 2 ... "The immune response elicited by LC16m8, a candidate smallpox vaccine that was developed in Japan by cold selection during serial passage of the ...
2009 NOV 1 ... examples from his other homeland security work with colleagues, including a bioterror smallpox attack, preventing nuclear weapons from entering the country on a shipping container, ...
2009 NOV 23 ... Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under development. ...
2009 NOV 2 ... Virus, and Biodefense applications including the rapid on-site detection of anthrax, smallpox, ricin and botulinum toxin. Several other product applications are under development. ...
2009 SEP 28 ... virus was administered widely to humans as a vaccine and led to the eradication of smallpox," researchers in the United States report. "We examined the therapeutic ...
2009 OCT 6 ... Keywords: Scotland, Cystic Fibrosis, Genetics, Hepatology, Inflammation, Pulmonology, Smallpox, University of Dundee. This article was prepared by Health Risk Factor Week ...
2009 NOV 2 ... Sciences of the United States of America, "Eczema vaccinatum (EV) is a complication of smallpox vaccination occurring in patients with atopic dermatitis. In affected individuals, ...
